Arkolith/Insider Trading/PHAS/Form 4

Hutson Nancy J

DirectorPhaseBio Pharmaceuticals Inc (PHAS) · full profile →Form 4 · filed Nov 8, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 8, 2021Option exercise(M)7K$3.15$23K34K
Nov 5, 2021Option exercise(M)2K$3.15$5K26K
Nov 5, 2021Option exercise(M)25K$2.26$56K25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 8, 2021Option exercise(M)7K$3.15$23K0
Nov 5, 2021Option exercise(M)2K$3.15$5K7K
Nov 5, 2021Option exercise(M)25K$2.26$56K2K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001169245-21-000106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML